𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prognostic significance of auer rods in childhood acute myelogenous leukemia: Results of the studies AML-BFM-78 and −83

✍ Scribed by Ritter, Jörg ;Vormoor, Josef ;Creutzig, Ursula ;Schellong, Günther


Publisher
John Wiley and Sons
Year
1989
Tongue
English
Weight
788 KB
Volume
17
Category
Article
ISSN
0098-1532

No coin nor oath required. For personal study only.

✦ Synopsis


The prognostic significance of Auer rods in predicting response rate and remission duration was investigated in 257 patients of the two West German acute myelogenous leukemia (AML) studies BFM-78 and -83. Auer rods were found in 129 children (50%) in the initial bone marrow smear. The incidence was higher in myeloid subtypes M1 (63%) and M2 (78%) compared with subtypes M4 (47%) and M5 (5%) with monocytic differentiation. In both studies, the remission rate was significantly higher in patients with Auer rods (P = 0.01), and in the study AML-BFM-83 a significantly longer remission duration was evaluated for Auer rod-positive patients (P = 0.007). In the M1 type, Auer rods were of high prognostic significance regarding both the induction success (P = 0.003) and the remission duration (P = 0.004), whereas no significant differences between Auer rod-positive and -negative patients in other subtypes were found. Occurrence of Auer rods was independent of hyperleukocytosis, the most powerful prognostic parameter in the studies AML-BFM-78 and -83, whereas absence of Auer rods was associated with the AML risk group M5. In the M1 type, Auer rod-negative leukemias appears to represent cases of poorly differentiated AML. Auer rods were therefore useful in differentiating between patients with a poor and a more favorable prognosis, particularly in the M1 type.


📜 SIMILAR VOLUMES


Mitoxantrone-containing regimen for trea
✍ Béhar, Catherine; Suciu, Stefan; Benoit, Yves; Robert, Alain; Vilmer, Etienne; B 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 505 KB

The objective of this study was to evaluate the feasibility, the toxicity and the efficiency of a BFM-like treatment protocol for acute nonlymphoblastic leukemia (ANLL) of children in which mitoxantrone was substituted for conventional anthracycline. The chemotherapy called for induction (mitoxantro